Medication Profile—Community Hospital
Date of admission: 2/13
Patient Name: Thomas Scott
Race: Caucasian
Address: 2523 Somewhere St.
Height: 5'9”
Age: 60
Weight: 162 lb
Gender: M
Allergies: NKA

Diagnosis
Atrial fibrillation, anemia, sigmoid diverticularis, glaucoma, hypertension, constipation, cough

Admission orders
 
Date
Name and Strength
Route
Sig
1.
2/13
Alphagan®
Ophthalmic
i gtt
2.
2/13
Citrucel®
PO
i tsp/8oz water qd
3.
2/13
Vitamin B12
IM
1000 mg qmo
4.
2/13
Timoptic® 0.5%
Ophthalmic
i gtt ou qam
5.
2/13
Xalatan® 0.005%
Ophthalmic
i gtt od qhs
6.
2/13
Lasix® 40 mg
PO
i qd
7.
2/13
Norvasc® 5 mg
PO
i qd
8.
2/13
Lotensin® 20 mg
PO
i qd
9.
2/13
Lanoxin® 0.125 mg
PO
i qd
10.
2/13
Coumadin® 4 mg
PO
i qd
11.
2/13
Senokot®
PO
ii qam
12.
2/13
Ferrous sulfate 325
PO
i qd
13.
2/13
Robitussin A-C®
PO
5–10 mL q4h
14.
2/13
Tylenol® 650 mg
PO
i q4h
15.
2/13
Adalat® 10 mg
PO
i prn if > 170/105
16.
2/13
Milk of magnesia 10 mL
PO
i qd prn
17.
2/13
Dulcolax® 10 mg supp
PR
i prn
 

Use the patient profile above to answer the following questions.

1.
Which of the drugs listed in Mr. Scott's profile is FDA approved to treat his atrial fibrillation?
I. Lanoxin®
II. Adalat®
III. Norvasc®
A.
I only
B.
II only
C.
III only
D.
I and II
E.
I, II, and III


2.
Types of drugs that are contraindicated for patients being treated for angle closure glaucoma include
I. Topical anticholinergics
II. Topical sympathomimetics
III. Calcium channel blockers
A.
I only
B.
II only
C.
III only
D.
I and II
E.
I, II, and III


3.
Which of the agents being used to treat Mr. Scott's glaucoma is a prostaglandin F2-alpha agonist?
I. Alphagan®
II. Xalatan®
III. Timoptic®
A.
I only
B.
II only
C.
III only
D.
I and II
E.
II and III


4.
At an early stage, vitamin B12-deficiency anemia is characterized by a
I. Decrease in red blood cell counts
II. Decrease in hematocrit values
III. Decrease in serum iron concentrations
A.
I only
B.
II only
C.
III only
D.
I and II
E.
II and III


5.
Mr. Scott has requested in his hospital meals more alfalfa and broccoli and would like to continue eating more of these kinds of vegetables from now on. In light of this change in his diet, the dose of which of the drugs listed in his profile would need to be adjusted?
I. Adalat®
II. Coumadin®
III. Lanoxin®
A.
I only
B.
II only
C.
III only
D.
I and II
E.
I, II, and III


6.
Dosage forms available for Norvasc® include
I. Tablet
II. Extended-release tablet
III. Capsule
A.
I only
B.
II only
C.
III only
D.
I and II
E.
I, II, and III


7.
Which of the following agents can increase the hypotensive effects of Norvasc®?
I. Adalat®
II. Alcoholic drinks
III. Rifadin®
A.
I only
B.
II only
C.
III only
D.
I and II
E.
II and III


8.
Lasix® is an effective therapy for all of the following EXCEPT
I. Hypertension
II. Management of edema associated with congestive heart failure
III. Nephropathy
A.
I only
B.
II only
C.
III only
D.
I and II
E.
I, II, and III


9.
Which of the following drugs would be better indicated when atrial fibrillation is precipitated by a high adrenergic state?
I. Inderal®
II. Adalat®
III. Cardizem®
A.
I only
B.
II only
C.
III only
D.
I and II
E.
II and II


10.
Active ingredients for Robitussin A-C® include
I. Guaifenesin
II. Codeine
III. Dextromethorphan
A.
I only
B.
II only
C.
III only
D.
I and II
E.
I, II, and III


11.
Which of the medications listed for Mr. Scott is likely to cause constipation?
I. Robitussin A-C®
II. Ferrous sulfate
III. Citrucel®
A.
I only
B.
II only
C.
III only
D.
I and II
E.
I, II, and III



STOP This is the end of the test. When you have completed all the questions and reviewed your answers, press the button below to grade the test.